Salem Investment Counselors Inc Palatin Technologies Inc Transaction History

Salem Investment Counselors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.37 - $0.54 $296 - $432	-800 Reduced 84.21%	150 $0
Q3 2021 Nov 15, 2021	BUY	$0.44 - $0.63 $352 - $504	800 Added 533.33%	950 $0
Q2 2019 Aug 14, 2019	BUY	$0.98 - $1.64 $147 - $245	150 New	150 $0
Q3 2018 Nov 14, 2018	SELL	$0.88 - $1.1 $132 - $165	-150 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$0.91 - $1.45 $136 - $217	150 New	150 $0
Q1 2018 May 15, 2018	SELL	$0.84 - $1.18 $126 - $177	-150 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$0.68 - $1.0 $102 - $150	150	150 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.